These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8297539)

  • 1. Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah.
    Williams RR; Hunt SC; Hopkins PN; Wu LL; Hasstedt SJ; Berry TD; Barlow GK; Stults BM; Schumacher MC; Ludwig EH
    Am J Hypertens; 1993 Nov; 6(11 Pt 2):319S-327S. PubMed ID: 8297539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension.
    Hunt SC; Wu LL; Hopkins PN; Stults BM; Kuida H; Ramirez ME; Lalouel JM; Williams RR
    Arteriosclerosis; 1989; 9(3):335-44. PubMed ID: 2497719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic heritability and common environmental components of resting and stressed blood pressures, lipids, and body mass index in Utah pedigrees and twins.
    Hunt SC; Hasstedt SJ; Kuida H; Stults BM; Hopkins PN; Williams RR
    Am J Epidemiol; 1989 Mar; 129(3):625-38. PubMed ID: 2916556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based frequency of dyslipidemia syndromes in coronary-prone families in Utah.
    Williams RR; Hopkins PN; Hunt SC; Wu LL; Hasstedt SJ; Lalouel JM; Ash KO; Stults BM; Kuida H
    Arch Intern Med; 1990 Mar; 150(3):582-8. PubMed ID: 2310276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
    Cubrilo-Turek M; Sertić J; Duraković Z
    Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of apolipoprotein E genotypes on plasma lipid and lipoprotein concentrations: results from a segregation analysis in pedigrees with molecularly defined familial hypercholesterolemia.
    Friedlander Y; Leitersdorf E
    Genet Epidemiol; 1996; 13(2):159-77. PubMed ID: 8722744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein(a) concentration does not differ between sexes in healthy offspring of patients with premature myocardial infarction.
    Barra S; Cuomo V; Silvestri N; Materazzi C; Vitagliano G; Capozzi G; Caruso S; Gaeta G; Trevisan M
    J Cardiovasc Med (Hagerstown); 2011 Jul; 12(7):482-6. PubMed ID: 21519277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of apolipoprotein B in members of a family with accelerated atherosclerosis: influence of apolipoprotein E-3/E-2 pattern.
    Haffner SM; Kushwaha RS; Hazzard WR
    Metabolism; 1992 Mar; 41(3):241-5. PubMed ID: 1542261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial dyslipidemic hypertension. Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension.
    Williams RR; Hunt SC; Hopkins PN; Stults BM; Wu LL; Hasstedt SJ; Barlow GK; Stephenson SH; Lalouel JM; Kuida H
    JAMA; 1988 Jun; 259(24):3579-86. PubMed ID: 3373705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ionizing radiation and genetic risks. VI. Chronic multifactorial diseases: a review of epidemiological and genetical aspects of coronary heart disease, essential hypertension and diabetes mellitus.
    Sankaranarayanan K; Chakraborty R; Boerwinkle EA
    Mutat Res; 1999 Jan; 436(1):21-57. PubMed ID: 9878681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein lipase gene mutations D9N and N291S in four pedigrees with familial combined hyperlipidaemia.
    de Bruin TW; Mailly F; van Barlingen HH; Fisher R; Castro Cabezas M; Talmud P; Dallinga-Thie GM; Humphries SE
    Eur J Clin Invest; 1996 Aug; 26(8):631-9. PubMed ID: 8872057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions.
    Ellis KL; Pang J; Chan DC; Hooper AJ; Bell DA; Burnett JR; Watts GF
    J Clin Lipidol; 2016; 10(6):1329-1337.e3. PubMed ID: 27919349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease.
    Zambon A; Brown BG; Deeb SS; Brunzell JD
    J Intern Med; 2006 May; 259(5):473-80. PubMed ID: 16629853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concordant dyslipidemia, hypertension and early coronary disease in Utah families.
    Williams RR; Hunt SC; Wu LL; Hopkins PN; Hasstedt SJ; Schumacher MC; Stults BM; Kuida H
    Klin Wochenschr; 1990; 68 Suppl 20():53-9. PubMed ID: 2189041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of three genetic loci in a pedigree with multiple lipoprotein phenotypes.
    Emi M; Hegele RM; Hopkins PN; Wu LL; Plaetke R; Williams RR; Lalouel JM
    Arterioscler Thromb; 1991; 11(5):1349-55. PubMed ID: 1655017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein and apolipoprotein abnormalities in familial combined hyperlipidemia: a 20-year prospective study.
    McNeely MJ; Edwards KL; Marcovina SM; Brunzell JD; Motulsky AG; Austin MA
    Atherosclerosis; 2001 Dec; 159(2):471-81. PubMed ID: 11730829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low density lipoprotein cholesterol, lipoprotein(a), and apo(a) isoforms in the elderly: relationship to fasting insulin. Associazione Medica Sabin.
    Carantoni M; Zuliani G; Bader G; Palmieri E; Volpato S; Passaro A; Imbastaro T; Mezzetti A; Fellin R
    Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):228-33. PubMed ID: 10656169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
    Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
    Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.